Chinese Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 2.6 billion in 2030
Roots Analysis is pleased to announce the publication of its recent study, titled, “China Biopharmaceutical Contract Manufacturing Market, 2021-2030.” Owing to benefits, such as reduced manufacturing costs, availability of cheap and skilled labor, and a supportive regulatory landscape, biopharmaceutical developers from across the globe, are increasingly outsourcing their...
0 Comments 0 Shares